Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders

Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders

Neurodevelopmental disorders (NDDs) are characterized by a wide range of symptoms including delayed speech, intellectual disability, motor dysfunction, social deficits, breathing problems, structural abnormalities, and epilepsy. Unfortunately, current treatment strategies are limited and innovative...

Full description

Bibliographic Details
Main Authors: Nicole M. Fisher, Mabel Seto, Craig W. Lindsley, Colleen M. Niswender
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-10-01
Series:Frontiers in Molecular Neuroscience
Subjects:
neurodevelopmental disorder
ASD
Rett syndrome
mGlu7
GRM7
allosteric modulator
Online Access:https://www.frontiersin.org/article/10.3389/fnmol.2018.00387/full

Internet

https://www.frontiersin.org/article/10.3389/fnmol.2018.00387/full

Similar Items